Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Cancer Research|2023Cited by 15
Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor–positive breast cancerShira Sherman, Rinath Jeselsohn|JCI Insight|2025Cited by 10
Figure 7 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Giacomo Oliveira et al.|Unknown|2023Cited by 0
Figure 5 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Unknown|2023Cited by 0
Supplementary Fig. S6 from Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast CancerFrancisco Hermida‐Prado, Rinath Jeselsohn, Yingtian Xie et al.|Unknown|2023Cited by 0